Is Ellume laying the foundations to list on the ASX?

Is Ellume coming to the ASX?

| More on:
Woman prepares to insert a swab in her nose to test for COVID-19 at home.

Image source: Getty Images

There have been a number of high profile initial public offerings (IPOs) in recent weeks. These include GQG Partners Inc. (ASX: GQG), SiteMinder Ltd (ASX: SDR), and Vulcan Steel Limited (ASX: VSL).

Potentially joining these shares on the ASX boards in the near future is COVID-testing kit company, Ellume.

Is Ellume going to launch an IPO soon?

According to the AFR, Ellume has been doing the groundwork for a potential listing in the near future.

The Queensland-based biotech has tasked stockbrokers Morgans and Ord Minnett to raise $85 million in a pre-IPO funding round. Sources have suggested that this will give Ellume a valuation in the range of $600 million to $800 million.

The report states that a spokesperson has confirmed that these pre-IPO funds would be used for working capital, sales and marketing, new product development, and capital expansion.

What does Ellume do?

Ellume is a biotechnology company that develops, manufactures, and commercialises the next generation of digital diagnostic products for healthcare professionals and consumers. Its focus is the accurate diagnosis of common infectious diseases.

The company came onto investor radars earlier this year after it signed a massive US$231 million contract with the US government to supply COVID-19 testing kits. This agreement was signed after its testing kit became the first non-prescription over-the-counter self-test authorised by the U.S. Food and Drug Administration.

The big question on investors’ lips if it does IPO will be how sustainable its current revenues are. When COVID-19 testing finally slows down, investors will be wanting assurance that Ellume’s revenues won’t dry up.

What are your other options?

Time will tell whether Ellume goes ahead with an IPO in the future. But in the meantime, if you’re wanting to gain exposure to COVID-19 testing, then you can do this through a number of ASX shares.

These include Healius Ltd (ASX: HLS) and Sonic Healthcare Limited (ASX: SHL). Both companies have been growing at an explosive rate over the last 18 months thanks to heightened demand for testing.

Should you invest $1,000 in Ellume right now?

Before you consider Ellume, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Ellume wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on IPOs

a man sits on a rocket propelled office chair and flies high above a city

Aurora Energy Metals share price rockets 35% on ASX debut

This lithium and uranium explorer debuted the ASX in style.

Read more »

Man in business suit above the clouds plummeting downwards back first

Chrysos Corporation share price plummets 40% on ASX debut

The ASX newbie offers a fresh way to analyse gold assays.

Read more »

Graphic showing a tablet with an IPO rocket going up with a stock market chart representing the upcoming IPO of ASX uranium and lithium share Aurora Energy Metals

New ASX uranium share to hit boards next month and investors are already pouncing

Introducing ASX uranium and lithium miner Aurora Energy Metals...

Read more »

A miner in a hardhat makes a sale on his tablet in the field.

This lithium miner is set to list on the ASX next month following its IPO, and counts a Tesla supplier among its key investors

We could be in for a new ASX debutant...

Read more »

A team celebrates a win in the office.

Newest battery minerals share booms 80% on ASX debut

Early investors in this ASX battery-focused company, rejoice!

Read more »

Energy Shares

This ASX energy share just hit the boards at double its IPO price

The ASX has a new energy stock and it's already proving a hit.

Read more »

Rocket takes off from the hand of a businessman.

Killi Resources (ASX:KLI) share price kills it on first day of trade, up 160%

Killi Resources shares soared 160% today. Have shareholders hit gold?

Read more »

A woman holds a glowing, sparking, technological representation of a planet in her hand.
Ask a Fund Manager

Expert reveals one IPO he’s absolutely pumped about. When will it hit the ASX?

Ask A Fund Manager: SG Hiscock's Rory Hunter tells why he's looking forward to one possible listing coming up later…

Read more »